Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Product
1.1.2 Technique
1.1.3 Application
1.1.4 End Use
1.1.5 Country scope
1.1.6 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 U.S. In Vitro Diagnostics (IVD) Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.3.1 Market Driver Analysis
3.3.2 Growing geriatric population
3.3.3 Technological advancements
3.3.4 Increasing demand for POC facilities
3.3.5 Growing prevalence of target diseases, such as genetic, cardiovascular, and neurological diseases, and hospital-acquired infections
3.3.6 Outbreak of covid-19
3.4 Market Restraint Analysis
3.4.1 Higher cost of devices
3.4.2 Stringent regulatory policies
3.5 SWOT Analysis, by factor (Political & Legal, Economic, and Technological)
3.6 Porter’s Five Forces Analysis
3.7 Major deals and strategic alliances analysis
3.7.1. New product launch
3.7.2. Mergers and acquisitions
3.7.3. Expansion
3.7.4. Partnerships
3.7.5. Marketing & promotions
3.7.6. Market entry strategies
3.8 Mergers and Deals
Chapter 4 U.S. In Vitro Diagnostics (IVD) Market: Segment Analysis, By Product, 2016 - 2027 (USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2019 & 2027
4.3 Segment Dashboard
4.4 U.S. In Vitro Diagnostics (IVD) Market, by Product, 2016 to 2027
4.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2016 - 2027
4.5.2 Reagents
4.5.2.1 Reagents market estimates and forecast, 2016 - 2027
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2016 - 2027
Chapter 5 U.S. In Vitro Diagnostics (IVD) Market: Segment Analysis, By Technology, 2016 - 2027 (USD Million)
5.1 Definition and Scope
5.2 Technology Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 U.S. In Vitro Diagnostics (IVD) Market, by Technology, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.5.1 Immunoassay
5.5.1.1 Immunoassay market estimates and forecast, 2016 - 2027
5.5.1.2 Instruments
5.5.1.2.1 Instruments market for immunoassay estimates and forecast, 2016 - 2027
5.5.1.3 Reagents
5.5.1.3.1 Reagents market for immunoassay estimates and forecast, 2016 - 2027
5.5.1.4 Services
5.5.1.4.1 Services market for immunoassay estimates and forecast, 2016 - 2027
5.5.2 Hematology
5.5.2.1 Hematology market estimates and forecast, 2016 - 2027
5.5.2.2 Instruments
5.5.2.2.1 Instruments market for hematology estimates and forecast, 2016 - 2027
5.5.2.3 Reagents
5.5.2.3.1 Reagents market for hematology estimates and forecast, 2016 - 2027
5.5.2.4 Services
5.5.2.4.1 Services market for hematology estimates and forecast, 2016 - 2027
5.5.3 Clinical Chemistry
5.5.3.1 Clinical Chemistry market estimates and forecast, 2016 - 2027
5.5.3.2 Instruments
5.5.3.2.1 Instruments market for clinical chemistry estimates and forecast, 2016 - 2027
5.5.3.3 Reagents
5.5.3.3.1 Reagents market for clinical chemistry estimates and forecast, 2016 - 2027
5.5.3.4 Services
5.5.3.4.1 Services market for clinical chemistry estimates and forecast, 2016 - 2027
5.5.4 Molecular Diagnostics
5.5.4.1 Molecular diagnostics market estimates and forecast, 2016 - 2027
5.5.4.2 Instruments
5.5.4.2.1 Instruments market for molecular diagnostics estimates and forecast, 2016 - 2027
5.5.4.3.Reagents
5.5.4.3.1 Reagents market for molecular diagnostics estimates and forecast, 2016 - 2027
5.5.4.4 Services
5.5.4.4.1 Services market for molecular diagnostics estimates and forecast, 2016 - 2027
5.5.4 Coagulation
5.5.4.1 Coagulation market estimates and forecast, 2016 - 2027
5.5.4 2 Instruments
5.5.4 2.1 Instruments market for coagulation estimates and forecast, 2016 - 2027
5.5.4 3 Reagents
5.5.4 3.1 Reagents market for coagulation estimates and forecast, 2016 - 2027
5.5.4 4 Services
5.5.4 4.1 Services market for coagulation estimates and forecast, 2016 - 2027
5.5.5 Microbiology
5.5.4.1 Microbiology market estimates and forecast, 2016 - 2027
5.5.4.2 Instruments
5.5.4.2.1 Instruments market for microbiology estimates and forecast, 2016 - 2027
5.5.4.3 Reagents
5.5.4.3.1 Reagents market for microbiology estimates and forecast, 2016 - 2027
5.5.4.4 Services
5.5.4.4.1 Services market for microbiology estimates and forecast, 2016 - 2027
5.5.5 Others
5.5.5.1 Others market estimates and forecast, 2016 - 2027
5.5.5.2 Instruments
5.5.5.2.1 Instruments Others market estimates and forecast, 2016 - 2027
5.5.5.3 Reagents
5.5.5.3.1 Reagents market estimates and forecast, 2016 - 2027
5.5.5.4 Services
5.5.5.4.1 Services market for other technology estimates and forecast, 2016 - 2027
Chapter 6 U.S. In Vitro Diagnostics (IVD) Market: Segment Analysis, By Application, 2016 - 2027 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 U.S. In Vitro Diagnostics (IVD) Market, by Application, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.5.1 Infectious Diseases
6.5.1.1 Infectious Diseases market estimates and forecast, 2016 - 2027
6.5.2 Diabetes
6.5.2.1 Diabetes market estimates and forecast, 2016 - 2027
6.5.3 Oncology
6.5.3.1 Oncology market estimates and forecast, 2016 - 2027
6.5.4 Cardiology
6.5.4.1 Cardiology market estimates and forecast, 2016 - 2027
6.5.5 Nephrology
6.5.5.1 Nephrology market estimates and forecast, 2016 - 2027
6.5.6 Autoimmune Diseases
6.5.6.1 Autoimmune Diseases market estimates and forecast, 2016 - 2027
6.5.7 Drug Testing
6.5.7.1 Drug Testing market estimates and forecast, 2016 - 2027
6.5.8 Others
6.5.8.1 Others market estimates and forecast, 2016 - 2027
Chapter 7 U.S. In Vitro Diagnostics (IVD) Market: Segment Analysis, By End Use, 2016 - 2027 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2019 & 2027
7.3 Segment Dashboard
7.4 U.S. In Vitro Diagnostics (IVD) Market, by End Use, 2016 to 2027
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
7.5.1 Hospitals
7.5.1.1 Hospitals market estimates and forecast, 2016 - 2027
7.5.1.2 Hospitals U.S. IVD instrument market estimates and forecast, 2016 - 2027
7.5.2 Laboratories
7.5.2.1 Laboratories Market estimates and forecast, 2016 - 2027
7.5.2.2 Laboratories U.S. IVD instrument market estimates and forecast, 2016 - 2027
7.5.3 Home-care
7.5.3.1 Home-care Market estimates and forecast, 2016 - 2027
7.5.3.2 Home-care U.S. IVD instrument market estimates and forecast, 2016 - 2027
7.5.4 Others
7.5.4.1 Other Market estimates and forecast, 2016 - 2027
7.5.4.2 Other U.S. IVD instrument market estimates and forecast, 2016 - 2027
Chapter 8 Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 Ansoff matrix
8.1.2 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
8.1.3 Innovators
8.2 Vendor Landscape
8.2.1 List of key distributors and channel partners
8.2.2 Key company market share analysis, 2018
8.3 Public Companies
8.3.1 Company market position analysis
8.3.2 Competitive Dashboard Analysis
8.3.3 Strategic FramewoRk
8.4 Private Companies
8.4.1 List of key emerging companies /technology disruptors/innovators
8.4.2 Regional network map
8.5 Company Profiles
8.5.1 Abbott
8.5.1.1 Company overview
8.5.1.2 Financial performance
8.5.1.3 Product benchmarking
8.5.1.4 Strategic initiatives
8.5.2 bioMerieux SA
8.5.2.1 Company overview
8.5.2.2 Financial Performance
8.5.2.3 Product benchmarking
8.5.2.4 Strategic initiatives
8.5.3 Bio-Rad Laboratories, Inc.
8.5.3.1 Company overview
8.5.3.2 Financial Performance
8.5.3.3 Product benchmarking
8.5.3.4 Strategic initiatives
8.5.4 Becton, Dickinson and Company
8.5.4.1 Company overview
8.5.4.2 Financial performance
8.5.4.3 Product benchmarking
8.5.4.4 Strategic initiatives
8.5.5 Siemens Healthineers AG
8.5.5.1 Company overview
8.5.5.2 Financial Performance
8.5.5.3 Product benchmarking
8.5.5.4 Strategic initiatives
8.5.6 Qiagen
8.5.6.1 Company overview
8.5.6.2 Financial performance
8.5.6.3 Product benchmarking
8.5.6.4 Strategic initiatives
8.5.7 Quidel Corporation
8.5.7.1 Company overview
8.5.7.2 Financial performance
8.5.7.3 Product benchmarking
8.5.7.4 Strategic initiatives
8.5.8 F. Hoffmann-La Roche AG
8.5.8.1 Company overview
8.5.8.2 Financial performance
8.5.8.3 Product benchmarking
8.5.8.4 Strategic initiatives
8.5.9 Sysmex Corporation
8.5.9.1 Company overview
8.5.9.2 Financial performance
8.5.9.3 Product benchmarking
8.5.9.4 Strategic initiatives
8.5.10 Charles River Laboratories International, Inc.
8.5.10.1 Company overview
8.5.10.2 Financial performance
8.5.10.3 Product benchmarking
8.5.10.4 Strategic initiatives
8.5.11 Quest Diagnostics
8.5.11.1 Company overview
8.5.11.2 Financial performance
8.5.11.3 Product benchmarking
8.5.11.4 Strategic initiatives
8.5.12 Agilent Technologies
8.5.12.1 Company overview
8.5.12.2 Financial performance
8.5.12.3 Product benchmarking
8.5.12.4 Strategic initiatives
8.5.13 Danaher Corporation
8.5.13.1 Company overview
8.5.13.2 Financial performance
8.5.13.3 Product benchmarking
8.5.13.4 Strategic initiatives
8.5.13.5 Strategic initiatives- Beckman Coulter, Inc.
8.5.13.6 Strategic initiatives- Leica Biosystems



List of Tables



TABLE 1 List of secondary sources
TABLE 2 List of Abbreviation
TABLE 3 Regulatory framework
TABLE 4 EUA IVD tests for COVID-19
TABLE 5 List of key distributors
TABLE 6 List of key emerging companies /technology disruptors/innovators
TABLE 7 U.S. IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 8 U.S. IVD Instrument Market, Type of Test, 2016 - 2027 Volume (Number of Units Installed)
TABLE 9 U.S. IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 10 U.S. Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 11 U.S. Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 12 U.S. Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 13 U.S. Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 14 U.S. Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 15 U.S. Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 16 U.S. Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 17 U.S. IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 18 U.S. IVD Market, by End Use, 2016 - 2027 (USD Million)
TABLE 19 U.S. IVD Instrument Market, Type of Provider, 2016 - 2027 Volume (Number of Units Installed)